Research Library
APEX — Mitochondrial EnergyAcetyl-L-Carnitine HCl

Acetyl-L-Carnitine

750 mg of the BBB-crossing carnitine form that shuttles fatty acids into mitochondria for energy production while donating acetyl groups to both the TCA cycle and acetylcholine synthesis — the molecular bridge between mitochondrial fuel and cholinergic cognition.

8 min read 5 Clinical Studies 750 mg per serving

Primacy Research

Key Benefits

What ALCAR Does For You

44% Reduction in Mental Fatigue

Malaguarnera et al. (2007) demonstrated a 44% reduction in mental fatigue scores over 6 months in elderly patients (p < 0.001) — vs. 12% in the placebo group.

Dual-Function Brain Molecule

ALCAR crosses the BBB and cleaves into L-carnitine (mitochondrial fuel shuttle) and an acetyl group (TCA cycle energy + acetylcholine synthesis) — bridging energy production and cholinergic cognition.

Mitochondrial Fatty Acid Shuttle

Restores the CPT-1/CACT/CPT-2 carnitine shuttle, enabling long-chain fatty acid transport into mitochondria for beta-oxidation — yielding 106 ATP per palmitate molecule.

Mood Support in Clinical Populations

Veronese et al. (2018) meta-analysis of 12 RCTs found ALCAR reduced depressive symptoms with an effect size of 1.10 and fewer reported side effects. Populations were largely elderly or medically ill.

NGF Receptor Sensitization

Preclinical evidence suggests ALCAR upregulates nerve growth factor receptor expression (p75NTR and TrkA) by 30–40% in basal forebrain cholinergic neurons — protecting the population most vulnerable to age-related decline.

The Problem

Your Brain’s Fuel Lines Are Clogging

Long-chain fatty acids are the brain’s most energy-dense fuel — a single palmitate molecule yields 106 ATP vs. 36 from glucose. But these fats can’t enter mitochondria without the carnitine shuttle. With age, tissue carnitine levels decline, creating a fuel delivery bottleneck — mitochondria have capacity but no substrate. The result: neurons with functional engines running on empty.

The Carnitine Shuttle Bottleneck

Long-chain fatty acids cannot cross the inner mitochondrial membrane without carnitine palmitoyltransferase (CPT-1/CPT-2). When carnitine levels drop, beta-oxidation — the brain’s most efficient energy pathway — becomes rate-limited regardless of mitochondrial health.

The Acetyl-CoA Triage

When acetyl-CoA pools are depleted, neurons face a triage: use it for ATP production (survival) or acetylcholine synthesis (cognition). Under energy stress, ATP wins, and cholinergic signaling collapses — manifesting as brain fog, impaired working memory, and reduced processing speed.

Age-Related Depletion

Tissue carnitine levels decline with age, accelerating after 40. Brain carnitine drops even faster due to reduced OCTN2 transporter expression. By 70, brain carnitine may be significantly below peak levels — degrading both energy production and neurotransmitter synthesis simultaneously.

Mechanism of Action

How ALCAR Works

Acetyl-L-Carnitine (ALCAR) is the acetylated form of L-carnitine — designed to cross the blood-brain barrier via OCTN2 and monocarboxylate transporters. The ‘acetyl’ prefix is the key differentiator: it carries an acetyl group that feeds both the TCA cycle and acetylcholine synthesis, making ALCAR a dual-function molecule.

01

BBB Crossing — Why Acetyl Matters

Standard L-carnitine cannot meaningfully cross the blood-brain barrier. ALCAR can — via OCTN2 and monocarboxylate transporters. Once inside neurons, ALCAR is cleaved into free L-carnitine (for the shuttle) and an acetyl group (for energy and neurotransmission). One molecule, two outputs.

02

The Carnitine Shuttle — Mitochondrial Fuel Delivery

Free L-carnitine activates the CPT-1/CACT/CPT-2 shuttle system, transporting long-chain fatty acyl-CoA across the inner mitochondrial membrane for beta-oxidation. Each palmitate yields 106 ATP — nearly 3x the energy of glucose oxidation.

03

Acetyl Group → TCA Cycle + Acetylcholine

The acetyl group enters the acetyl-CoA pool directly, feeding the TCA cycle for immediate ATP production without requiring full beta-oxidation — a metabolic shortcut. It also serves as a substrate for choline acetyltransferase (ChAT), producing acetylcholine for cholinergic neurotransmission.

04

NGF Receptor Sensitization

Preclinical evidence suggests ALCAR upregulates nerve growth factor (NGF) receptor expression (p75NTR and TrkA) in basal forebrain cholinergic neurons — with receptor density increases of ~30–40% observed in aged models. This protects the neuronal population most vulnerable to age-related degeneration.

05

Mitochondrial Membrane Stabilization

ALCAR is thought to support cardiolipin integrity in the inner mitochondrial membrane (essential for Complex IV function), reduces toxic acyl-CoA accumulations, and buffers the CoA/acyl-CoA ratio — preventing metabolic paralysis under stress.

Clinical Evidence

What the Research Shows

ALCAR is backed by over two decades of clinical research including large meta-analyses and randomized controlled trials across cognitive decline, fatigue, and mood.

2003 Meta-Analysis21 double-blind RCTs · n=~1,204
21
RCTs Analyzed
Consistent cognitive benefit, effect increasing with duration
3 mo
Time to Significant Benefit
Effect grew over 3–12 months (Montgomery et al.)

Montgomery et al. (2003). International Clinical Psychopharmacology, 18(2):61-71. Meta-analysis of 21 RCTs in MCI/mild AD. ALCAR 1,500-3,000 mg/day. Significant benefit on clinical and psychometric measures.

2007 RCTDouble-blind, placebo-controlled · n=96
44%
Reduction in Mental Fatigue
ALCAR 2,000 mg/day for 6 months (p < 0.001)
Fatigue Scores — ALCAR vs. Placebo (6 Months)
ALCAR Mental
−44%
Placebo Mental
−12%
ALCAR Physical
Sig. ↓

Malaguarnera, M., et al. (2007). Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Archives of Gerontology and Geriatrics, 46(2), 181–190.

2018 Meta-AnalysisSystematic review · 12 RCTs · n=791
1.1
SMD vs. Placebo for Depression
Large effect size for mood improvement in clinical populations (p < 0.001)

Veronese et al. (2018). Psychosomatic Medicine, 80(2):154-159. ALCAR significantly reduced depressive symptoms. Effect size noted in largely elderly or medically ill populations.

Dosage & Bioavailability

Your Daily Dose in APEX

Clinical Range
1,500–3,000 mg
Per day in monotherapy RCTs
APEX Delivers
750 mg
ALCAR per serving — optimized within the mitochondrial + cholinergic stack
BBB-Crossing Form
ALCAR
vs. L-Carnitine which cannot meaningfully enter the brain

Why this dose works: Clinical trials typically used 1,500–3,000 mg/day in cognitively impaired populations. APEX delivers 750 mg — below the 1,500–3,000 mg range used in most clinical trials. The lower dose is a formulation trade-off; evidence for synergistic dose reduction is theoretical. This dose is positioned within a comprehensive mitochondrial stack (BioPQQ, Na-R-ALA, Di-Mag Malate) where each component addresses a different rate-limiting step. BioPQQ® creates new mitochondria to receive the fuel ALCAR delivers, Na-R-ALA handles the oxidative cost of increased beta-oxidation, Di-Mag Malate provides Krebs cycle substrate, and Citicoline shares the cholinergic load by providing choline for ACh synthesis. The Ames lab (Liu et al., 2002, PNAS) showed ALCAR + alpha-lipoic acid combination reversed age-related mitochondrial decay more effectively than either alone at higher doses.

Formula Synergy

How ALCAR Connects Across the System

ALCAR is the molecular bridge between APEX’s mitochondrial energy stack and its cholinergic cognitive stack — designed to simultaneously feed both systems. Its connections extend into RESET’s overnight repair cycle.

APEX

The Ames Lab Synergy

Liu et al. (2002, PNAS) at UC Berkeley demonstrated that ALCAR + alpha-lipoic acid reversed age-related mitochondrial decay in aged rats — restoring mitochondrial membrane potential, reducing oxidative damage, and improving cognitive function to near-youthful levels in preclinical models. Neither compound alone achieved the same magnitude of effect. APEX is designed to replicate this pairing: ALCAR (750 mg) + Na-R-ALA (100 mg) — a well-studied mitochondrial combination in aging research.

APEX

The Dual-Function Bridge

ALCAR is the molecule in APEX designed to bridge the mitochondrial energy system and the cholinergic cognitive system. Its carnitine component feeds fatty acid fuel into mitochondria. Its acetyl group feeds both the TCA cycle (energy) and acetylcholine synthesis (cognition). Combined with Citicoline (choline supply), ALCAR is positioned to support both sides of the ACh equation.

APEX → RESET

24-Hour Mitochondrial Fuel Cycle

APEX’s ALCAR drives fatty acid fuel delivery during waking hours of cognitive demand. RESET continues mitochondrial support overnight: CoQ10 replenishes electron transport capacity, S-Acetyl Glutathione replenishes the antioxidant buffer consumed during the day, and Di-Mag Malate (550 mg in RESET) sustains Krebs cycle throughput during sleep-phase repair.

Summary

Key Takeaways

01

44% Less Mental Fatigue

Malaguarnera et al. (2007) demonstrated ALCAR reduced mental fatigue scores by 44% over 6 months in elderly patients — vs. 12% in the placebo group. The effect was statistically significant at p < 0.001.

02

The Ames Lab Benchmark

The ALCAR + alpha-lipoic acid combination (Liu et al., 2002, PNAS) In aged rat models, ALCAR + ALA reversed age-related mitochondrial decay to near-youthful levels. APEX uses the same combination of ingredients with ALCAR (750 mg) + Na-R-ALA (100 mg).

03

The BBB-Crossing Carnitine

L-Carnitine cannot meaningfully enter the brain. ALCAR can — via OCTN2 and MCT transporters. The acetyl group that enables BBB penetration also feeds acetylcholine synthesis — making ALCAR a dual-function CNS molecule.

04

Mitochondrial-Cholinergic Bridge

ALCAR is the APEX ingredient designed to simultaneously feed the mitochondrial energy stack (carnitine shuttle → beta-oxidation → TCA cycle) and the cholinergic cognitive stack (acetyl group → acetylcholine). Combined with Citicoline, it is positioned to support both energy production and neurotransmitter synthesis so neither is acetyl-CoA-limited.

FAQ

Frequently Asked Questions

What is Acetyl-L-Carnitine (ALCAR)?

ALCAR is the acetylated form of L-carnitine — a naturally occurring amino acid derivative. The acetyl group allows it to cross the blood-brain barrier (unlike standard L-carnitine) and serve as both a mitochondrial fuel transporter and an acetyl donor for acetylcholine synthesis.

How is ALCAR different from L-Carnitine?

Standard L-carnitine cannot meaningfully cross the blood-brain barrier. ALCAR can — via OCTN2 and monocarboxylate transporters. Once inside neurons, ALCAR splits into free L-carnitine (for the mitochondrial shuttle) and an acetyl group (for energy and neurotransmitter production). For cognitive applications, ALCAR is the only relevant form.

What does ALCAR do for the brain?

ALCAR supports brain function through two simultaneous mechanisms: (1) its carnitine component drives fatty acid fuel into mitochondria for ATP production, and (2) its acetyl group feeds both the TCA energy cycle and acetylcholine synthesis. Clinical evidence shows reductions in mental fatigue and support for mood and cognitive function.

Why is the APEX dose 750 mg instead of the clinical trial doses of 1,500–3,000 mg?

Clinical trials used 1,500–3,000 mg/day as monotherapy in cognitively impaired populations. Inside APEX, ALCAR works within an integrated mitochondrial stack (BioPQQ®, Na-R-ALA, Di-Mag Malate) where each ingredient addresses a different rate-limiting step. The Ames lab (Liu et al., 2002) showed ALCAR + alpha-lipoic acid together were more effective than either alone at higher doses.

What is the Ames Lab synergy?

In 2002, Bruce Ames’ lab at UC Berkeley published in PNAS that ALCAR combined with alpha-lipoic acid reversed age-related mitochondrial decay in aged rats, restoring mitochondrial membrane potential and cognitive function to near-youthful levels. APEX uses the same combination of ingredients: ALCAR (750 mg) + Na-R-ALA (100 mg).

How much ALCAR is in APEX?

APEX delivers 750 mg of Acetyl-L-Carnitine HCl per serving. This is at the lower end of the studied clinical range, optimized for synergistic delivery within APEX’s full mitochondrial and cholinergic stack rather than monotherapy dosing.

References

References

  1. [1]
    Montgomery, S. A., Thal, L. J., & Amrein, R. (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer’s disease. International Clinical Psychopharmacology, 18(2), 61–71.View
  2. [2]
    Malaguarnera, M., et al. (2007). Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Archives of Gerontology and Geriatrics, 46(2), 181–190.View
  3. [3]
    Veronese, N., Stubbs, B., Solmi, M., Ajnakina, O., Carvalho, A. F., & Maggi, S. (2018). Acetyl-L-carnitine supplementation and the treatment of depressive symptoms: A systematic review and meta-analysis. Psychosomatic Medicine, 80(2), 154–159.View
  4. [4]
    Liu, J., Head, E., Gharib, A. M., Yuan, W., Ingersoll, R. T., Hagen, T. M., Cotman, C. W., & Ames, B. N. (2002). Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoic acid. PNAS, 99(4), 2356–2361.View

Upgrade Your Mitochondrial Fuel System

ALCAR is one of 28 active ingredients in APEX, engineered to work as a system — not a stack of standalone compounds.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.